The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.
Affirm Holdings Inc (NASDAQ: AFRM) shares are trading lower Tuesday after Walmart Inc (NYSE: WMT) slashed guidance for the second quarter and full fiscal year.